Drug Stock Due for Another Climb on the Charts
TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's
TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's
Teva Pharmaceutical Stock Could Double | Barron's
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva stock drops on guidance, manufacturing problems - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva's generic EpiPen approved in the U.S., with perfect timing - MarketWatch
Teva stock drops on guidance, manufacturing problems - MarketWatch
Prosecutors Sue Teva's U.S. Business Over Charitable Donations - WSJ
Teva Pharmaceutical Stock Could Double | Barron's
Investors wary of Teva-Mylan merger - MarketWatch
Drug maker Teva's U.S. unit indicted on price-fixing charges - MarketWatch
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Mylan sees opportunity in rival Teva's weakness - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
Teva Stock Jumps Following Tentative Deal to Settle Opioid Cases | Barron's
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
